Eiger's phase II study of ubenimex in lower leg lymphedema does not meet endpoints Oct. 17, 2018 No Comments
SHIP2 is key in FGF signaling and necessary for the maintenance of FGF-mediated ERK activation Oct. 15, 2018 No Comments
The flavonoid fisetin inhibits senescence and reduces age-related pathologies in elderly mice Oct. 8, 2018 No Comments
Beta1-integrin promotes endothelial barrier disruption: a new target to prevent vascular leakage Sep. 7, 2018 No Comments
Galecto Biotech compound is an orally available drug for fibrosis and cancer Aug. 28, 2018 No Comments
Discovery of a novel, orally available, transient receptor potential channel 6 inhibitor Aug. 28, 2018 No Comments
RSS